Beranda › Atrofi Geografis
Uji klinis Atrofi Geografis yang merekrut di AS
24 studi untuk Atrofi Geografis merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Reno, NV8 studi
- Dallas, TX8 studi
- Santa Monica, CA7 studi
- Austin, TX7 studi
- Cleveland, OH6 studi
- Baltimore, MD6 studi
- The Woodlands, TX6 studi
- Houston, TX6 studi
- Naperville, IL6 studi
- Spokane, WA5 studi
- St. Louis, MO5 studi
- Erie, PA5 studi
- San Antonio, TX5 studi
- Washington, DC5 studi
- Sacramento, CA5 studi
- Hagerstown, MD5 studi
- Philadelphia, PA4 studi
- Nashville, TN4 studi
- Raleigh, NC4 studi
- Durham, NC4 studi
- Lynchburg, VA4 studi
- St. Petersburg, FL4 studi
- Fort Worth, TX4 studi
- McAllen, TX3 studi
- Phoenix, AZ3 studi
- Abilene, TX3 studi
- Huntington Beach, CA3 studi
- Syracuse, NY3 studi
- Concord, CA3 studi
- Carmel, IN3 studi
- Pensacola, FL3 studi
- Lewisville, TX3 studi
- Sarasota, FL3 studi
- Cincinnati, OH3 studi
- San Francisco, CA3 studi
- Eugene, OR3 studi
- Escondido, CA3 studi
- Salt Lake City, UT3 studi
- Boston, MA3 studi
- Mountain View, CA3 studi
Berdasarkan negara bagian
- Arizona5 studi
- California13 studi
- Colorado4 studi
- Connecticut4 studi
- Florida8 studi
- Georgia4 studi
- Illinois9 studi
- Indiana3 studi
- Maryland7 studi
- Massachusetts7 studi
- Michigan5 studi
- Mississippi3 studi
- Missouri5 studi
- Nevada8 studi
- New Jersey3 studi
- New York4 studi
- North Carolina7 studi
- Ohio7 studi
- Oregon4 studi
- Pennsylvania9 studi
- South Carolina4 studi
- Tennessee4 studi
- Texas15 studi
- Utah4 studi
- Virginia4 studi
- Washington6 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Menerima pesertaFase 2/3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06635148Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
Menerima pesertaFase 1/2
Usia 55 hingga 95 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT04339764A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Menerima pesertaFase 1/2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07029945A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
Menerima pesertaFase 2
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06557460A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Menerima pesertaFase 1/2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07215234A Study in Adults With Geographic Atrophy
Menerima pesertaFase 2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Menerima pesertaFase 3
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Menerima pesertaFase 2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Menerima pesertaStudi observasional
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07144137A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT03178149Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06662162SGLT2 Inhibitors in Geographic Atrophy
Menerima pesertaFase 2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07174687A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07594236Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07230834Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Menerima pesertaFase 1/2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT07160179Stem Cell Ophthalmology Treatment Study II
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT03011541High Resolution Retinal Imaging
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 7 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT01866371Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
Menerima pesertaStudi observasional
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT07556406Progression of Early Atrophic Lesions
Menerima pesertaStudi observasional
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT05959005A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
Menerima pesertaFase 1/2
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT07158775A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2025 · NCT06805474Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2024 · NCT05438732Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.